Cargando…

Patients Selection for Immunotherapy in Solid Tumors: Overcome the Naïve Vision of a Single Biomarker

Immunotherapy, and in particular immune-checkpoints blockade therapy (ICB), represents a new pillar in cancer therapy. Antibodies targeting Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4) and Programmed Death 1 (PD-1)/Programmed Death Ligand-1 (PD-L1) demonstrated a relevant clinical value in a large numb...

Descripción completa

Detalles Bibliográficos
Autores principales:	Signorelli, Diego, Giannatempo, Patrizia, Grazia, Giulia, Aiello, Marco Maria, Bertolini, Federica, Mirabile, Aurora, Buti, Sebastiano, Vasile, Enrico, Scotti, Vieri, Pisapia, Pasquale, Cona, Maria Silvia, Rolfo, Christian, Malapelle, Umberto, Group, Immune-Oncology YOUNG
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6507101/ https://www.ncbi.nlm.nih.gov/pubmed/31179334 http://dx.doi.org/10.1155/2019/9056417

Ejemplares similares

Targeted therapy and non-small cell lung cancer: a new era!
por: Malapelle, Umberto, et al.
Publicado: (2019)

The next frontier of early lung cancer and minimal residual disease detection: is multiomics the solution?
por: Rolfo, Christian, et al.
Publicado: (2023)

A narrative review of lung cancer cytology in the times of coronavirus: what physicians should know
por: Pisapia, Pasquale, et al.
Publicado: (2020)

A strategy to overcome EGFR p.T790M cis p.L792F induced resistance to osimertinib
por: Malapelle, Umberto, et al.
Publicado: (2022)

Next Generation Sequencing and Genetic Alterations in Squamous Cell Lung Carcinoma: Where Are We Today?
por: Friedlaender, Alex, et al.
Publicado: (2019)

Uncommon EGFR Compound Mutations in Non-Small Cell Lung Cancer (NSCLC): A Systematic Review of Available Evidence
por: Attili, Ilaria, et al.
Publicado: (2022)

Editorial: Emerging Biomarkers for NSCLC: Recent Advances in Diagnosis and Therapy
por: Malapelle, Umberto, et al.
Publicado: (2021)

Less frequently mutated genes in colorectal cancer: evidences from next-generation sequencing of 653 routine cases
por: Malapelle, Umberto, et al.
Publicado: (2016)

Diagnostic and prognostic biomarkers in oligometastatic non-small cell lung cancer: a literature review
por: Cortinovis, Diego, et al.
Publicado: (2021)

Can Computers Become Conscious and Overcome Humans?
por: Signorelli, Camilo Miguel
Publicado: (2018)

The prognostic impact of tumor mutational burden (TMB) in the first-line management of advanced non-oncogene addicted non-small-cell lung cancer (NSCLC): a systematic review and meta-analysis of randomized controlled trials
por: Galvano, A., et al.
Publicado: (2021)

KRAS detection on archival cytological smears by the novel fully automated polymerase chain reaction-based Idylla mutation test
por: De Luca, Caterina, et al.
Publicado: (2017)

EML4-ALK translocation identification in RNA exosomal cargo (ExoALK) in NSCLC patients: a novel role for liquid biopsy
por: Reclusa, Pablo, et al.
Publicado: (2019)

BRAF: A Two-Faced Janus
por: Pisapia, Pasquale, et al.
Publicado: (2020)

Comments on roles of circulating tumor cells in the metastatic cascade and tumor immune escape: biology and clinical translation
por: Serrano, Maria Jose, et al.
Publicado: (2023)

中国肺癌低剂量CT筛查指南（2023年版）
por: Chinese Expert Group on Early Diagnosis and Treatment of Lung Cancer,, et al.
Publicado: (2023)

Understanding EGFR heterogeneity in lung cancer
por: Passaro, Antonio, et al.
Publicado: (2020)

Small Cell Lung Cancer: State of the Art of the Molecular and Genetic Landscape and Novel Perspective
por: Denninghoff, Valeria, et al.
Publicado: (2021)

Editorial: Beyond chemotherapy and immunotherapy in thoracic malignancies: Overcoming resistance by tackling new molecular pathways
por: Mountzios, Giannis, et al.
Publicado: (2022)

USP11 role in colorectal cancer growing and metastatisation
por: Malapelle, Umberto
Publicado: (2019)

KRAS, NRAS and BRAF mutations detected by next generation sequencing, and differential clinical outcome in metastatic colorectal cancer (MCRC) patients treated with first line FIr-B/FOx adding bevacizumab (BEV) to triplet chemotherapy
por: Bruera, Gemma, et al.
Publicado: (2018)

EGFR exon 19 deletion switch and development of p.L792Q mutation as a new resistance mechanism to osimertinib: a case report and literature review
por: Pisapia, Pasquale, et al.
Publicado: (2019)

Pazopanib as a possible option for the treatment of metastatic non-clear cell renal carcinoma patients: a systematic review
por: Bersanelli, Melissa, et al.
Publicado: (2020)

Clinical Significance of Early Changes in Circulating Tumor Cells from Patients Receiving First-Line Cisplatin-Based Chemotherapy for Metastatic Urothelial Carcinoma(1)
por: Fina, Emanuela, et al.
Publicado: (2016)

New Insight to Overcome Tumor Resistance: An Overview from Cellular to Clinical Therapies
por: Mitola, Giulia, et al.
Publicado: (2021)

Editorial: Second Line Treatment of Non-Small Cell Lung Cancer: Clinical, Pathological and Molecular Aspects of Novel Promising Drugs
por: Malapelle, Umberto, et al.
Publicado: (2017)

Editorial: Molecular pathology and computational image analyses in gynecologic malignancies
por: Malapelle, Umberto, et al.
Publicado: (2022)

Editorial: Long non-coding RNAs in lung cancer
por: Malapelle, Umberto, et al.
Publicado: (2022)

Next Generation Sequencing in Cytopathology: Focus on Non-Small Cell Lung Cancer
por: Pisapia, Pasquale, et al.
Publicado: (2021)

Next generation sequencing in cytology
por: Pisapia, Pasquale, et al.
Publicado: (2021)

Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer 2018 (English version)
por: diagnosis and treatment guidelines for colorectal cancer working group, Chinese Society of Clinical Oncology (CSCO)
Publicado: (2019)

PD-1 Inhibitors-Related Neurological Toxicities in Patients with Non-Small-Cell Lung Cancer: A Literature Review
por: Mirabile, Aurora, et al.
Publicado: (2019)

Redox Signaling Modulates Activity of Immune Checkpoint Inhibitors in Cancer Patients
por: Allegra, Alessandro, et al.
Publicado: (2023)

Aging and Age-Related Epigenetic Drift in the Pathogenesis of Leukemia and Lymphomas: New Therapeutic Targets
por: Allegra, Alessandro, et al.
Publicado: (2023)

From targeting the tumor to targeting the immune system: Transversal challenges in oncology with the inhibition of the PD-1/PD-L1 axis
por: Bersanelli, Melissa, et al.
Publicado: (2017)

Cabozantinib in metastatic renal cell carcinoma: latest findings and clinical potential
por: Bersanelli, Melissa, et al.
Publicado: (2017)

Overcoming TKI resistance in fusion-driven NSCLC: new generation inhibitors and rationale for combination strategies
por: Russo, Alessandro, et al.
Publicado: (2020)

BRCA1/2 NGS Somatic Testing in Clinical Practice: A Short Report
por: Pepe, Francesco, et al.
Publicado: (2021)

Biomarkers predictive value in early stage non-small cell lung cancer
por: Malapelle, Umberto, et al.
Publicado: (2020)

Editorial: Diagnosis and Treatment of Breast Cancer in 2022: The Rise of Novel Molecular Biomarkers
por: Fusco, Nicola, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_deka3bc3drm116esdoaj5dsa2k